An Experimental Obesity Pill Mimics Gastric Bypass Surgery

In the MIT on the MIT, Giovanni Traverso, a stomach-donoerologist and mechanical engineer and Robert Langer, is a chemical engineer launched by more than two biotechnics.

The two discovered the mechanism while working on a road to develop a liquid formulia to be given to children. Soon these temporary synthetic cover could be able to make more or less transversion or more to slow down or slow down. The latter ability was as attractive as treatment for obesity.

“This material is something you take as a capsule or liquid, but the next day, the next day went due to the natural turnover of our mucosal surface in our tract,” he said. In 2022, Dhanda and Langer and Langer said the violent scythe. These covers are like mussels and other crusty fish are used to stick to rocks or ocean.

The results were announced, drugs were delivered to a liquid through a pipe through a pipe to check that polymer coatings are as expected. The form of a tablet has already been tested in pigs and dogs, and this is the plans to test in future human research.

A six-week work period in rats in rats, while maintaining 100 percent of the weight of lean muscle, a consecutive 1 percent weight loss consistent on a consecutive 1 percent work period.

The first human pilot study consisting of nine participants was safe without any adverse effects. Tissue samples taken from the intestine were used to confirm that the cover was formed and cleaned from the body within 24 hours. The study was designed to lose weight, but the blood test, glucose levels and the “hunger hormone” grade, but the level of a hormone regulating the appetite was higher.

“When nutrients in the intestine are then redirected, you activate the ways that cause saturation, energy costs and common healthy, sustainable weight loss,” he said.

Synthis Bio’s findings in animals, the Musless Mass, the current GLP-1 medication point to the weight of the muscle masses to lose weight. We usually lose weight with multiple health benefits, there are grow up evidence The sharp loss of weight loss can cause the loss of the lean muscle mass of GLP-1S.

Although a obesity medical professional and professor and professor, GLP-1S will not be suitable for anyone, although the Weill-Cornell Medical College is wildly popular. In the future, the future predicts that there will be many drugs for obesity and treatment and the treatment will be more individual. “I think the combination of the synchor is perfectly fit as a treatable treatment. It is something you can use as a first line medication,” he says. Incoming, it serves as a clinical advisor of the company.

Vladimir Kushnir says the director of Bariatric Endoscopy at Washington University in St. Louis, which is not affiliated with medical professors and synthis, but it is difficult to draw any results as a result of such a small investigation. The drug will make people feel fuller, but it expects the same side effects as a stomach bypass operation. “My eyes are that it enters a larger study, as well as the digestive side effects such as bloating and abdominal cramp, as well as potentially some diarrhea and heartburn.

This is the first days of this novel technique, but if it is effective, it can be an alternative or additional medication to GLP-1 medicine one day.